Stay updated on PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial
Sign up to get notified when there's something new on the PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial page.

Latest updates to the PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now presents the completed Phase 1 study comparing PF-06438179 with U.S. and EU infliximab in healthy volunteers, including its design, eligibility criteria, study location, and measured outcomes.SummaryDifference42%

- Check18 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide banner announces an NIH transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check32 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content and navigation. This indicates access to the record is restricted.SummaryDifference17%

Stay in the know with updates to PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial page.